Peter Bergethon, MD

Linkedin Team icon

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Dr. Bergethon is the Vice President and Head of Digital and Quantitative Medicine at Biogen Inc., where he leads the effort to transform clinical trials and humanize drug discovery by encouraging the transition of clinical trial measures from a qualitative to a quantitative discipline. The Quantitative Medicine transformation has advanced Biogen’s leadership in neuroscience therapeutics and personalized medicine. Dr. Bergethon came to Biogen in 2017 from Pfizer Worldwide Research and Development where he was Vice President and Head of the Pfizer Innovation Research Lab within the Early Clinical Development group.

Before joining the biopharmaceutical industry in 2012, Dr. Bergethon spent 30 years in academic medicine as a Professor at Boston University and Tufts University in the Departments of Biochemistry, Neurology, Neurobiology & Anatomy, and Biomedical Engineering. Dr. Bergethon graduated from Williams College with honors in biology for research in neurocybernetics and then earned an M.D. from Jefferson Medical College. He is board-certified in internal medicine and neurology following dual residencies at Boston City Hospital. Dr. Bergethon received his formal science training through the National Institutes of Health’s Physician-Scientist training in biophysical chemistry at Boston University School of Medicine. He then completed a fellowship training in EEG and neurophysiology at Lahey Clinic-Hitchcock Medical Center in Burlington, MA. In 1995, Dr. Bergethon received the American Academy of Neurology’s Founders’ Award. Dr. Bergethon has written and contributed to over 130 research papers and books and is the single author of “The Physical Basis of Biochemistry: The Foundations of Molecular Biophysics”, 2nd Ed.

Robert Barrow Portrait

Robert Barrow

Chief Executive Officer and Board Director

Miri Halperin Wernli, PhD Portrait

Miri Halperin Wernli, PhD

Executive President and Board Director

Cynthia Hu, JD Portrait

Cynthia Hu, JD

Chief Legal Officer & Corporate Secretary

Daniel Karlin, MD, MA Portrait

Daniel Karlin, MD, MA

Chief Medical Officer

Schond Greenway, MBA Portrait

Schond Greenway, MBA

Chief Financial Officer

Francois Lilienthal, MD, MBA Portrait

Francois Lilienthal, MD, MBA

Chief Commercial Officer

Robert Silva, PhD Portrait

Robert Silva, PhD

VP, Head of Development

Robert Malenka, MD, PhD Portrait

Robert Malenka, MD, PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Peter Bergethon, MD Portrait

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Dworkin, PhD Portrait

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Maurizio Fava, MD Portrait

Maurizio Fava, MD

Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Maria Oquendo, MD, PhD Portrait

Maria Oquendo, MD, PhD

Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania

Bridget Walton, MS Portrait

Bridget Walton, MS

VP, Global Regulatory Affairs

Kenneth Alper, MD Portrait

Kenneth Alper, MD

Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine

Peter Gasser, MD Portrait

Peter Gasser, MD

Clinical Advisor

Stanley D Glick, MD PhD Portrait

Stanley D Glick, MD PhD

Scientific Advisor

Matthew W Johnson, PhD Portrait

Matthew W Johnson, PhD

Clinical Advisor

Kim PC Kuypers, PhD Portrait

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Matthias Liechti, MD, PhD Portrait

Matthias Liechti, MD, PhD

Scientific Collaborator & Advisor

Carol Vallone Portrait

Carol Vallone

Chair of the Board of Directors, Chair of Compensation Committee, Member of Audit/Finance Committee

Natalie Wheeler, PhD Portrait

Natalie Wheeler, PhD

Medical Science Liaison with Dova Pharmaceuticals

John Rotrosen, MD Portrait

John Rotrosen, MD

Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry

Andreas Krebs Portrait

Andreas Krebs

Vice Chair of the Board of Directors, Chair of Nomination and Governance Committee, Member of Audit/Finance Committee

Brigid Makes Portrait

Brigid Makes

Board Director, Chair of Audit/Finance Committee, Member of Compensation Committee, Member of Nomination and Governance Committee

Carrie Liao, CPA Portrait

Carrie Liao, CPA

VP, Corporate Controller & Principal Accounting Officer

Peter Mack, PhD Portrait

Peter Mack, PhD

VP, Pharmaceutical Development

Carole Abel, MBA Portrait

Carole Abel, MBA

VP, Programs and Portfolio Office (PPO)